Skip to content
Catalyst

knowcompoundsphosphate(3-)

Specimen compound inorganic compound, anionPlate I

Phosphate

Nested hairline contours trace the electron density of one computed shape of phosphate(3-), teal at the edge warming to amber over the atoms.

432 readings, by contour and atom

fig. 1Phosphate · electron density · PubChem CID 1061, computed 3D conformer
Formula
O4P3−
Molar mass
94.97 g/mol
PubChem CID
1061
InChIKey
NBIIXXVUZAFLBC-UHFFFAOYSA-K

↑ raised 3 findings in 2 endpoints · ↓ lowered 1 in 1 · – no difference found 3 in 3

01 · the evidence, ordered

What the evidence says

Strong
0
Moderate
1
Limited
0
Very limited
5
Insufficient
1

How to read these marks

Fig. 2 Phosphate CHEBI:18367 5 endpoints 7 findings
×1.60
Labels
CompoundInspector

Phosphate

Most findings

  • Maximal oxygen uptake×2
  • Postprandial energy expenditure (ventilated hood indirect calorimetry)×2
  • Ad libitum test-meal energy intake×1
  • Time-trial completion time×1
  • Waist circumference×1

24 reference statements, not drawn · 36 compounds on the outer ring, not drawn

Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

  1. Waist circumference
  2. Maximal oxygen uptakecontested
  3. Postprandial energy expenditure (ventilated hood indirect calorimetry)
  4. Ad libitum test-meal energy intake
  5. Time-trial completion time
fig. 3 · 5 endpoints · 7 findingscontested · an endpoint whose findings disagree

02 · contested · 1 endpoint

Where the findings disagree

  1. 012 findings

    Maximal oxygen uptake

    – no difference found
    1
    ↑ raised
    1

03 · findings

What phosphate moved, and by how much

  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed
Direction
Strength, at least

7 shown

  1. Waist circumferenceMoved: lowersEvidence: ModeratePaper: PMID 266902872015
    Who
    Overweight or obese adults aged 18-45 years (BMI 25 or above, normal kidney function) at one Beirut university; 47 completers, 26 phosphorus and 21 placebo; change from baseline to 12 weeks
    Dose studied
    three tablets containing 375 mg phosphorus with each main meal (breakfast, lunch, dinner), 12 weeks

    Simultaneously, waist circumference of the phosphorus group was significantly reduced by 3.62 cm (95% CI −4.90 to −2.33), and this reduction was significantly different (P<0.001) from the small increase of 0.38 cm (95% CI −0.44 to 1.20) in the waist circumference of the placebo group.”

    Quoted verbatim from Effect of phosphorus supplementation on weight gain and waist circumference of overweight/obese adults: a randomized clinical trial.RCT · 3 monthsPermalink
  2. Postprandial energy expenditure (ventilated hood indirect calorimetry)Moved: raisesEvidence: Very limitedreplicated ×1Paper: PMID 305096382018
    Who
    Healthy lean men given iso-caloric (554 kcal) normal-protein or high-protein meals, each with or without phosphorus
    Dose studied
    500 mg phosphorus with a meal, single occasion per visit

    NPr and HPr meals had similar postprandial energy expenditure and this was significantly increased (P = 0.005) by P ingestion.”

    Quoted verbatim from Postprandial energy expenditure of protein is affected by its phosphorus content.crossoverPermalink
  3. Ad libitum test-meal energy intakeMoved: no difference foundEvidence: Very limitedPaper: PMID 228049722012
    Who
    20 trained men and women, double-blind counterbalanced crossover; laboratory meal on Days 1, 2 and 6 of each 6-day phase, acute dose (Day 1) and prolonged supplementation
    Dose studied
    sodium phosphate 50 mg/kg fat-free mass per day for 6 days, versus placebo

    There was no difference in energy intake at the laboratory meal after an acute dose (i.e., on Day 1; placebo 2,471 ± 919 kJ, phosphate 2,353 ± 987 kJ; p = .385) or prolonged supplementation with sodium phosphate (p = .581) compared with placebo.”

    Quoted verbatim from The effect of 6 days of sodium phosphate supplementation on appetite, energy intake, and aerobic capacity in trained men and women.crossover · 6 daysPermalink
  4. Postprandial energy expenditure (ventilated hood indirect calorimetry)Moved: raisesEvidence: Very limitedreplicated ×1Paper: PMID 301535802019
    Who
    Overnight-fasted lean and obese men given a high-carbohydrate meal (648 kcal) with placebo or phosphorus tablets
    Dose studied
    500 mg phosphorus tablets with a meal, single occasion

    Phosphorus ingestion with a meal increased the postprandial energy expenditure of both lean and obese individuals (P < 0.001), although in different patterns.”

    Quoted verbatim from Phosphorus ingestion with a high-carbohydrate meal increased the postprandial energy expenditure of obese and lean individuals.crossoverPermalink
  5. Time-trial completion timeMoved: no difference foundEvidence: Very limitedPaper: PMID 370871032023
    Who
    16 well-trained cyclists, randomised single-blind crossover, 30-km cycling time trial after 4 days of loading, 14-day washout
    Dose studied
    dibasic sodium phosphate 3.5 g/day (Na2HPO4, 24.7 mmol/day phosphate) for 4 days; comparator sodium chloride matched for sodium (49.4 mmol/day)

    Time to complete the 30-km time trial did not differ following ingestion of sodium phosphate and sodium chloride (3,059 ± 531 s vs. 2,995 ± 467 s).”

    Quoted verbatim from Phosphate Loading Does not Improve 30-km Cycling Time-Trial Performance in Trained Cyclists.crossover · 4 daysPermalink
  6. Maximal oxygen uptakecontestedMoved: no difference foundEvidence: Very limitedPaper: PMID 228049722012
    Who
    20 trained men and women, double-blind counterbalanced crossover; peak aerobic capacity measured after the 6 days of supplementation
    Dose studied
    sodium phosphate 50 mg/kg fat-free mass per day for 6 days, versus placebo

    Likewise, there was no difference in VO(2peak) with phosphate supplementation (placebo 52.6 ± 5.2 ml · kg(-1) · min(-1), phosphate 53.3 ± 6.1 ml · kg(-1) · min(-1); p = .483).”

    Quoted verbatim from The effect of 6 days of sodium phosphate supplementation on appetite, energy intake, and aerobic capacity in trained men and women.crossover · 6 daysPermalink
  7. Maximal oxygen uptakecontestedMoved: raisesEvidence: InsufficientPaper: PMID 23558231990
    Who
    Seven male competitive runners, double-blind placebo-controlled crossover with a 2-week washout, maximal running stress test · n = 7
    Dose studied
    1000 mg tribasic sodium phosphate four times daily for 6 days

    Phosphate loading significantly increased maximal oxygen uptake from 4.77 +/- 0.29 to 5.18 +/- 0.25 l.min-1 and ventilatory anaerobic threshold from 3.74 +/- 0.28 to 4.18 +/- 0.14 l.min-1.”

    Quoted verbatim from Effects of phosphate loading on oxygen uptake, ventilatory anaerobic threshold, and run performance.crossover · 6 daysPermalink

No dose is advised.

  • Dose studied: as its paper gave it.
  • Evidence strength: computed from the study. How it is computed

04 · identity

Structure

fig. 4Phosphate · 2D structure · ChEBI’s SMILES
fig. 5Phosphate · 3D conformer · PubChem CID 1061, computed
Charge
-3
SMILES
O=P([O-])([O-])[O-]

05 · figures · 2 plates

Plates

  • Hairline isopotential curves around one computed shape of phosphate(3-), teal where the potential is negative and amber where it is positive.
    fig. 6Phosphate · electrostatic potential, molecular plane · PubChem CID 1061, computed 3D conformer
  • Rings of hairline contours on a lattice, each the computed X-ray reflection of phosphate(3-)'s crystal, strong spots ringed many times and weak ones once.
    fig. 7Phosphate · h0l zone, computed · COD 1007097 (Averbuch-Pouchot et al. 1983, HNa₃O₄.₅P, C 1 2/c 1) · kinematic |F|², Cromer-Mann form factors, B 2 Ų

06 · reach

What it touches on the way

6 entities · assembled from reference reactions

  1. SLC25A10Protein270 paths · 45 endpointsinferred
  2. SLC17A7Protein34 paths · 32 endpointsinferred
  3. SLC37A4Protein4 paths · 2 endpointsinferred
  4. SLC20A1Protein4 paths · 2 endpointsinferred
  5. SLC34A1Protein3 paths · 3 endpointsinferred
  6. SLC20A2Protein2 paths · 1 endpointinferred
The chain of Protein PML drawn as banded hairlines, with phosphate(3-)'s small contour map where it sits bound in PDB 10TH.
fig. 8Phosphate in Protein PML (Homo sapiens) · PDB 10TH chain A, ligand PO4 (Fairchild et al. 2026, 3.01 Å)

Where it reaches

21 regions · transporter routes

  1. Brainnervous2 routesinferred
  2. Female reproductivereproductive2 routesinferred
  3. Male reproductivereproductive2 routesinferred
  4. Adrenal glandendocrine1 routeinferred
  5. Airway and sinusesrespiratory1 routeinferred
  6. Bladderurinary1 routeinferred
  7. Blood and immuneimmune1 routeinferred
  8. Blood vesselscardiovascular1 routeinferred
  9. Breastreproductive1 routeinferred
  10. Colon and rectumdigestive1 routeinferred
  11. Gallbladderdigestive1 routeinferred
  12. Heartcardiovascular1 routeinferred
Show the remaining 9Show the first 12
  1. Liverdigestive1 routeinferred
  2. Lungrespiratory1 routeinferred
  3. Mouth and oesophagusdigestive1 routeinferred
  4. Pancreasendocrine1 routeinferred
  5. Skeletal musclemusculoskeletal1 routeinferred
  6. Skinintegumentary1 routeinferred
  7. Small intestinedigestive1 routeinferred
  8. Stomachdigestive1 routeinferred
  9. Thyroidendocrine1 routeinferred

07 · documented · reference

Interactions

Documented interactions
None reported

Pairs that share biology

What the reference databases state

Reference statements
2401 ProteinSLC17A1, SLC17A2, SLC17A3, SLC17A4, SLC17A7, SLC20A1, and 7 moreinferred, one hop from phosphate
Reactions · Rhea
857reactions
24Reference statements

What the reference databases state

Evidence key

Statements

24 statements

phosphate(3-) is transported by each

Show the remaining 1Show the first 12
857Reactions

08 · on the label · 4,292 products

Labelled products

Source: NIH DSLD · Ingredient: phosphate(3-) · 4,292 products · Declared amount per serving (the first 1,000 shown): 0.06–1,330 mg

903 labels of the first 1,000 shown state an amount97 do not

  • 'Merica LabzPatriot's Whey Chubby Choco Nutzamount not statedper 37.8 gDSLD:213358
  • 21st CenturyDiabetic Support FormulaPhosphorus, as Dicalcium Phosphate48 mgper 3 tabletsDSLD:11189
  • 21st CenturyHair, Skin & NailsPhosphorus, as Dicalcium Phosphate58 mgper 1 tabletDSLD:205740
  • 21st CenturyImmuBlast-C Raspberry Burst FlavorPhosphorus, as Potassium Phosphate, Dicalcium Phosphate, Sodium Phosphate, electrolytes38 mgper 9 gDSLD:205527
  • 21st CenturyImmuBlast-C Ultimate Orange FlavorPhosphorus, as Potassium Phosphate, Dicalcium Phosphate, Sodium Phosphate, electrolytes38 mgper 9 gDSLD:205521
  • 21st CenturyOne Daily ActivePhosphorus, as Calcium Phosphate48 mgper 1 tabletDSLD:11548
  • 21st CenturyOne Daily MaximumPhosphorus, as Calcium Phosphate109 mgper 1 tabletDSLD:11558
  • 21st CenturySentry AdultsPhosphorus, as Dicalcium Phosphate20 mgper 1 tabletDSLD:207458
  • 21st CenturySentry EnergyPhosphorus, as Dicalcium Phosphate48 mgper 1 tabletDSLD:207442
  • 21st CenturySentry SeniorPhosphorus, as Dicalcium Phosphate20 mgper 1 tabletDSLD:207452
  • 21st Century ReNourishWhey Protein ChocolatePhosphorus, as Dicalcium Phosphate150 mgper 30 gDSLD:208342
  • 21st Century ReNourishWhey Protein Vanilla BeanPhosphorus, as Dicalcium Phosphate150 mgper 30 gDSLD:208359
Show the remaining 4,280Show the first 12

Label record: NIH Office of Dietary Supplements · CC0

09 · the record

Sources

128

papers screened for phosphate

admitted
6
read and discarded
102
not read yet
20

The screening record, every paper and why

Sources cited

6 papers · 7 findings

Show every paper citedHide the papers cited

Other names · 12

[PO4](3-) · [PO4]3− · Orthophosphate · Phosphate · PHOSPHATE ION · PO4(3-) · PO43−

systematic · tetraoxidophosphate(3-)

systematic · tetraoxidophosphate(3−)

systematic · tetraoxophosphate(3-)

systematic · tetraoxophosphate(3−)

systematic · tetraoxophosphate(V)

318Endpoints measured, not recorded as findingsEvery row, on one page
28Papers indexed under phosphate